Preclinical Partners Identified

Strategic collaborations have been established with reputable UK based contract research organizations to support the next stages of preclinical development.

These partners provide capabilities in GLP toxicology studies, expanded in vivo efficacy testing, CMC dossier preparation, and analytical chemistry including stability validation. These relationships position the program to advance efficiently toward regulatory ready preclinical data.